News Vitamin B12 study hints at a molecular mechanism for acne pathogenesis Taking vitamin B12 supplements affects the genes expressed by bacteria living on our skin, report researchers at the University of California, Los Angeles in Science Translational Medicine.…Published: 30 June 2015
News Make sunscreen protection rating clearer, urges pharmacist organisation The Royal Pharmaceutical Society calls on sunscreen manufacturers to adopt single sun protection rating after survey reveals public confusion.…Published: 26 June 2015
News Trauma to joints can increase risk of psoriatic arthritis Patients with psoriasis who experience trauma to the joints or bones are up to 50% more likely to go on to develop psoriatic arthritis, finds new research.…Published: 24 June 2015
Opinion Onion skin cells make an effective muscle actuator Treating onion skin cells with sulphuric acid and gold allow them to be used as a muscle simulator.…Published: 21 May 2015
News Boots’ sunscreen lotion fails sun protection test, says Which? Two sunscreens, including one manufactured by Boots, have failed sun protection tests, according to research conducted by the UK consumer watchdog Which? …Published: 19 May 2015
News Tildrakizumab shows promise as psoriasis treatment Merck reports in a phase I trial that its new monoclonal antibody, tildrakizumab, reduces psoriasis symptoms.…Published: 30 March 2015
News Diuretic reduces skin atrophy associated with corticosteroid creams Spironolactone, used to treat fluid retention in patients with oedema, heart failure and hypertension, can also alleviate side effects from corticosteroid-based creams used for certain skin conditions, according to research.…Published: 27 March 2015
News Study reveals high levels of non-adherence to acne treatments A survey reveals that patients prescribed treatments for acne do not always adhere to their prescribed medicines.…Published: 27 March 2015
Opinion Putting cosmeceuticals in context ‘Handbook of cosmeceutical excipients and their safeties’, by Kwan Yu Heng, Tung Yee Kei, Kochhar Jaspreet Singh, Li Hairui, Poh Ai-Ling and Kang Lifeng.…Published: 12 February 2015
News First-in-class oral drug approved for psoriasis conditions in Europe The European Commission has authorised apremilast (Celgene’s Otezla), a first-in-class oral drug for the treatment of chronic plaque psoriasis and psoriatic arthritis in patients who have failed first-line systemic therapies.…Published: 30 January 2015
